Viewing records where tag name contains "asx" View All

VIRALEZE SPL7013 virucidal against multiple COVID variants (ASX Announcement)

Jun 18th, 2021

Starpharma today released new data demonstrating that SPL7013, the active in VIRALEZE antiviral nasal spray, achieved more than 99.9% reduction of virus against the Alpha (UK), Beta (South Africa) and Gamma (Japan/Brazil) SARS-CoV-2 coronavirus ‘Variants of Concern’ in laboratory-based virucidal assays.

Read More